ACLA Welcomes Sarah Thibault-Sennett, PhD, as Senior Director of Reimbursement Policy
Washington, D.C. – The American Clinical Laboratory Association (ACLA) has welcomed Sarah Thibault-Sennett, PhD, as Senior Director of Reimbursement Policy.
“Sarah’s deep knowledge of reimbursement and regulatory policy issues and her experience as a laboratory scientist will enhance ACLA’s work to advance policy that fosters innovation and expands patient access to quality laboratory testing services being delivered every day by ACLA members across the country,” said Susan Van Meter, President of ACLA. “We are gratified to have Sarah join ACLA.”
At ACLA, Sarah will serve a key role in the association’s work supporting innovation in laboratory services that deliver life-saving results for patients and pave the access pathway for future clinical laboratory advancements. She will focus on ensuring that reimbursement policies provide appropriate access to testing for patients and the health care providers who detect, prevent, manage, and diagnose acute, chronic, and infectious diseases through the power of clinical laboratory testing.
Sarah was previously the Director of Public Policy & Advocacy at the Association for Molecular Pathology (AMP). She has a strong background in patient engagement and regulatory issues affecting molecular pathology, as well as molecular genetics and developmental biology. She transitioned into public policy with the goal of increasing patient access to appropriate diagnostic testing.
Sarah holds a PhD in Molecular and Cell Biology from the Uniformed Services University of the Health Sciences (USU) in Bethesda, MD, as well as a Bachelor of Science degree in Biology from Bucknell University.
ACLA is the national trade association representing leading laboratories that deliver essential diagnostic health information to patients and providers. ACLA members are at the forefront of driving diagnostic innovation to meet the country’s evolving health care needs and provide vital clinical laboratory tests that identify and prevent infectious, acute, and chronic disease. ACLA works to advance the next generation of health care delivery through policies that expand access to lifesaving testing services.